Biogen Inc. (BIIB) Social Stream
Biogen Inc (BIIB) Price Targets From Analysts
Use the tables below to see what analysts covering Biogen Inc think about its future price and what recommendations they have for investors and traders.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 26 | $647 | $300 | $417 | $285.26 | 46.18% |
The Trend in the Analyst Price Target
Over the past 29 weeks, BIIB's average price target has gone up $125.63.
Over the past 16 months, BIIB's average upside potential has been 14.71%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-09-20 | 26 | 647 | 300.0 | 417.00 | 298.49 | 39.7% |
| 2021-09-19 | 26 | 647 | 300.0 | 417.00 | 300.19 | 38.91% |
| 2021-09-18 | 26 | 647 | 300.0 | 417.00 | 300.19 | 38.91% |
| 2021-09-11 | 27 | 647 | 300.0 | 417.70 | 299.81 | 39.32% |
| 2021-09-04 | 28 | 647 | 300.0 | 417.07 | 333.60 | 25.02% |
| 2021-08-28 | 28 | 647 | 279.1 | 413.50 | 343.19 | 20.49% |
| 2021-08-14 | 28 | 647 | 279.1 | 413.50 | 342.25 | 20.82% |
| 2021-08-07 | 29 | 647 | 279.1 | 414.42 | 340.00 | 21.89% |
| 2021-08-05 | 29 | 647 | 279.1 | 414.42 | 336.59 | 23.12% |
| 2021-08-01 | 29 | 647 | 244.0 | 410.21 | 326.73 | 25.55% |
| 2021-07-24 | 29 | 647 | 244.0 | 407.93 | 325.40 | 25.36% |
| 2021-07-17 | 27 | 647 | 244.0 | 410.67 | 324.62 | 26.51% |
| 2021-07-10 | 27 | 647 | 244.0 | 404.34 | 358.16 | 12.89% |
| 2021-07-03 | 27 | 647 | 244.0 | 404.08 | 348.72 | 15.88% |
| 2021-06-26 | 27 | 647 | 244.0 | 406.12 | 347.93 | 16.72% |
| 2021-06-13 | 27 | 500 | 244.0 | 390.49 | 396.64 | -1.55% |
| 2021-06-05 | 29 | 458 | 157.0 | 287.87 | 286.14 | 0.6% |
| 2021-05-22 | 29 | 458 | 157.0 | 287.87 | 283.19 | 1.65% |
| 2021-05-15 | 29 | 458 | 157.0 | 287.00 | 280.21 | 2.42% |
| 2021-05-08 | 28 | 458 | 157.0 | 286.97 | 274.04 | 4.72% |
| 2021-04-25 | 29 | 458 | 157.0 | 288.90 | 262.63 | 10% |
| 2021-04-17 | 29 | 458 | 166.0 | 290.00 | 270.31 | 7.28% |
| 2021-04-10 | 29 | 458 | 166.0 | 289.97 | 268.17 | 8.13% |
| 2021-04-03 | 29 | 458 | 166.0 | 289.76 | 278.71 | 3.96% |
| 2021-03-20 | 29 | 458 | 166.0 | 289.76 | 267.07 | 8.5% |
| 2021-03-13 | 29 | 458 | 166.0 | 289.76 | 266.13 | 8.88% |
| 2021-03-06 | 29 | 458 | 166.0 | 289.76 | 270.71 | 7.04% |
| 2021-02-27 | 30 | 458 | 166.0 | 291.37 | 272.88 | 6.78% |
| 2021-02-20 | 30 | 458 | 166.0 | 291.67 | 278.35 | 4.79% |
| 2021-02-13 | 29 | 458 | 166.0 | 292.38 | 278.03 | 5.16% |
| 2021-02-06 | 29 | 458 | 175.0 | 290.72 | 265.09 | 9.67% |
| 2021-01-30 | 29 | 450 | 175.0 | 296.90 | 282.61 | 5.06% |
| 2021-01-23 | 29 | 450 | 175.0 | 293.03 | 269.44 | 8.76% |
| 2021-01-16 | 29 | 450 | 175.0 | 291.55 | 275.84 | 5.7% |
| 2021-01-09 | 29 | 450 | 175.0 | 290.48 | 252.54 | 15.02% |
| 2021-01-02 | 30 | 450 | 175.0 | 290.27 | 244.86 | 18.55% |
| 2020-12-26 | 30 | 450 | 175.0 | 290.27 | 248.89 | 16.63% |
| 2020-12-19 | 30 | 450 | 175.0 | 291.40 | 249.62 | 16.74% |
| 2020-12-09 | 30 | 450 | 175.0 | 291.40 | 244.75 | 19.06% |
| 2020-12-07 | 30 | 450 | 175.0 | 291.40 | 243.68 | 19.58% |
| 2020-11-28 | 30 | 450 | 175.0 | 290.37 | 243.78 | 19.11% |
| 2020-11-18 | 28 | 450 | 175.0 | 292.89 | 240.98 | 21.54% |
| 2020-11-06 | 28 | 450 | 175.0 | 292.71 | 328.90 | -11% |
| 2020-10-27 | 28 | 357 | 200.0 | 289.46 | 255.30 | 13.38% |
| 2020-10-05 | 27 | 386 | 228.0 | 305.11 | NA | NA% |
| 2020-09-17 | 27 | 386 | 228.0 | 304.96 | NA | NA% |
| 2020-09-01 | 27 | 386 | 228.0 | 305.22 | NA | NA% |
| 2020-08-22 | 27 | 386 | 228.0 | 305.22 | NA | NA% |
| 2020-08-07 | 27 | 386 | 228.0 | 306.89 | NA | NA% |
| 2020-07-24 | 27 | 390 | 228.0 | 297.44 | NA | NA% |
| 2020-07-14 | 27 | 390 | 228.0 | 296.74 | NA | NA% |
| 2020-07-07 | 28 | 392 | 228.0 | 304.21 | NA | NA% |
| 2020-06-19 | 28 | 392 | 228.0 | 304.11 | NA | NA% |
| 2020-06-18 | 28 | 392 | 228.0 | 308.39 | NA | NA% |
| 2020-06-08 | 28 | 410 | 240.0 | 319.96 | NA | NA% |
BIIB Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.62 | 8 | 8 | 16 | 0 | 0 | 32 |
The Trend in the Broker Recommendations
BIIB's average broker recommendation rating improved by 0.3 over the prior 20 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for BIIB as an investment opportunity.
- The average analyst price target of BIIB is higher than 98.34% of all US stocks.
- The number of analysts covering the stock of BIIB is greater than 99.86% of Pharmaceutical Products stocks.
- The variance in analysts' estimates of BIIB is less than 8.18000000000001% of all US stocks.
- Biogen Inc's upside potential (average analyst target price relative to current price) is greater than 89.7% of stocks in the large market cap category.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Biogen Inc are LLY, REGN and VRTX.
What is the outlook for BIIB? Use POWR Ratings for clearer insight into price direction.